Shandong Weigao completes H-share buyback, adjusts issued share count

Shandong Weigao Group Medical Polymer Company Limited, an equity issuer listed on the Exchange, reported a share repurchase on September 12, 2025. The company bought back 319,600 H-shares on the Exchange at prices ranging from HKD 5.77 to HKD 5.9 per share, with an aggregate price paid of HKD 1,878,508. These repurchased shares are to be held as treasury shares.

Following this transaction, the number of issued shares (excluding treasury shares) decreased from 4,505,230,724 to 4,504,911,124, representing a 0.0071% change. The number of treasury shares increased from 17,101,600 to 17,421,200. The total number of issued shares remains 4,522,332,324.

The repurchase was conducted under a mandate granted on May 27, 2025, which authorized the company to repurchase a total of 451,560,392 shares. As of the repurchase date, 10,772,800 shares have been repurchased on the Exchange, representing 2.3857% of the issued shares (excluding treasury shares) at the time of the mandate. A moratorium period for new share issues or sales of treasury shares is in effect until October 12, 2025.